With annual reverification season, or “blizzard season,” rapidly approaching, life sciences organizations must consider the challenges facing their patient support program processes (PSP), and how the right PSP vendor can help overcome these challenges for both pharmacy and medical benefit products.
In this Drug Channels article, Patient Solutions Division President Jan Nielsen details how life sciences organizations should evaluate how patient support program vendors adapt to a changing landscape through technology, talent off-ramps and specialty pharmaceutical expertise.
Drug Channels is one of the industry’s leading publications offering expert insights on pharmaceutical economics and the drug distribution systems.